Phenylpropanolamine and stroke: The study, the FDA ruling, the implications

  • Cleveland Clinic Journal of Medicine
  • March 2001,
  • 68
  • (3)
  • 208-223;

ABSTRACT

Following a recent case-control study that linked the use of phenylpropanolamine (PPA) in diet aids to the risk of hemorrhagic stroke, the Food and Drug Administration requested that drug companies stop marketing products that contain PPA. Dozens of over-the-counter and prescription diet aids and cough and cold remedies will need to be reformulated or discontinued. This paper reviews the study and its implications for physicians.

Loading
PDF
Back to top

In this issue

Cleveland Clinic Journal of Medicine

Cleveland Clinic Journal of Medicine

Vol. 68, Issue 3

1 Mar 2001

Table of Contents Table of Contents (PDF) Index by author
  • Share

    Share This Article

    Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
    • Cleveland Clinic Journal of Medicine
    • March 2001,
    • 68
    • (3)
    • 208-223;

Jump to section